Anti-leukemia responses can only occur when there are high-avidity leukemia-specific CD8+ T cells present. Additionally, repeated peptide vaccinations can result in the selective elimination of these high-avidity CD8+ T cells, leading to a decrease in anti-leukemia responses. Here, CD8A is linked to leukemia.